The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Prevalence, Clinical Profile, and Significance of Left Ventricular Remodeling in the End-Stage Phase of Hypertrophic Cardiomyopathy
Abstract
Background— End stage (ES) is a recognized part of the hypertrophic cardiomyopathy (HCM) disease spectrum. Frequency, clinical profile and course, and treatment strategies in these patients remain incompletely defined. Methods and Results— Three HCM cohorts comprised 1259 patients, including 44 (3.5%) characterized as ES with systolic dysfunction (ejection fraction <50% at rest; range 15% to 49%). ES developed at a wide age range (14 to 74 years), with 45% of patients ≤40 years old. Although 29 patients (66%) died of progressive heart failure, had sudden death events, or underwent heart transplantation, 15 (34%) survived with medical management over 3±3 years. Duration from onset of HCM symptoms to ES identification was considerable (14±10 years), but ES onset to death/transplantation was brief (2.7±2 years). ES occurred with similar frequency in patients with or without prior myectomy ( P =0.84). Appropriate defibrillator interventions were 10% per year in patients awaiting donor hearts. Most ES patients (n=23; 52%) showed substantial left ventricular (LV) remodeling with cavity dilatation. Less complete remodeling occurred in 21 patients (48%), including 5 with persistence of a nondilated and markedly hypertrophied LV. Pathology and magnetic resonance imaging showed extensive (transmural) fibrosis in 9 of 11 ES patients. At initial evaluation, patients who developed ES were younger with more severe symptoms, had a larger LV cavity, and more frequently had a family history of ES than other HCM patients. Conclusions— ES of nonobstructive HCM has an expanded and more diverse clinical expression than previously appreciated, including occurrence in young patients, heterogeneous patterns of remodeling, frequent association with atrial fibrillation, and impaired LV contractility that precedes cavity dilatation, wall thinning, and heart failure symptoms. ES is an unfavorable complication (mortality rate 11% per year) and a sudden death risk factor; it requires vigilance to permit timely recognition and the necessity for defibrillator implantation and heart transplantation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Recommendations for Quantitation of the Left Ventricle by Two-Dimensional Echocardiography
Schiller, N. B., Shah, P. M., Crawford, M., DeMaria, A., Devereux, R., Feigenbaum, H., Gutgesell, H., Reichek, N., Sahn, D., Schnittger, I., et al. (1989) · Journal of the American Society of Echocardiography · doi:10.1016/s0894-7317(89)80014-8 · Cited by 8,121
Zoghbi, W. A., Enriquez-Sarano, M., Foster, E., Grayburn, P. A., Kraft, C. D., Levine, R. A., Nihoyannopoulos, P., Otto, C. M., Quinones, M. A., Rakowski, H., et al. (2003) · Journal of the American Society of Echocardiography · doi:10.1016/s0894-7317(03)00335-3 · Cited by 4,044
Hypertrophic Cardiomyopathy: A Systematic Review
Maron, B. J. (2002) · JAMA · doi:10.1001/jama.287.10.1308 · Cited by 2,224
Self-citationMaron, B. J., McKenna, W. J., Danielson, G. K., Kappenberger, L. J., Kuhn, H. J., Seidman, C. E., Shah, P. M., Spencer, W. H., Spirito, P., Ten Cate, F. J., et al. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00941-0 · Cited by 1,578
Self-citationMaron, M. S., Olivotto, I., Betocchi, S., Casey, S. A., Lesser, J. R., Losi, M. A., Cecchi, F., & Maron, B. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021332 · Cited by 1,259
Self-citationThe Genetic Basis for Cardiomyopathy
Seidman, J. G., & Seidman, C. (2001) · Cell · doi:10.1016/s0092-8674(01)00242-2 · Cited by 1,046
Sudden death in hypertrophic cardiomyopathy: identification of high risk patients
Elliott, P. M., Poloniecki, J., Dickie, S., Sharma, S., Monserrat, L., Varnava, A., Mahon, N. G., & McKenna, W. J. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)01003-2 · Cited by 978
Maron, B. J., Shen, W.-K., Link, M. S., Epstein, A. E., Almquist, A. K., Daubert, J. P., Bardy, G. H., Favale, S., Rea, R. F., Boriani, G., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200002103420601 · Cited by 832
Self-citationCoronary Microvascular Dysfunction and Prognosis in Hypertrophic Cardiomyopathy
Cecchi, F., Olivotto, I., Gistri, R., Lorenzoni, R., Chiriatti, G., & Camici, P. G. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa025050 · Cited by 782
Intramural (“small vessel”) coronary artery disease in hypertrophic cardiomyopathy
Maron, B. J., Wolfson, J. K., Epstein, S. E., & Roberts, W. C. (1986) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(86)80181-4 · Cited by 756
Self-citationMoon, J. C. C., Reed, E., Sheppard, M. N., Elkington, A. G., Ho, S., Burke, M., Petrou, M., & Pennell, D. J. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.03.035 · Cited by 696
Klues, H. G., Schiffers, A., & Maron, B. J. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00390-8 · Cited by 656
Self-citationBasso, C. (2000) · Human Pathology · doi:10.1053/hupa.2000.16659 · Cited by 418
Shirani, J., Pick, R., Roberts, W. C., & Maron, B. J. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00492-1 · Cited by 408
Self-citationMaron, B. J., Epstein, S. E., & Roberts, W. C. (1979) · The American Journal of Cardiology · doi:10.1016/0002-9149(79)90139-5 · Cited by 385
Self-citationMaron, B. J., & Roberts, W. C. (1979) · Circulation · doi:10.1161/01.cir.59.4.689 · Cited by 366
Self-citationSpirito, P., Maron, B. J., Bonow, R. O., & Epstein, S. E. (1987) · The American Journal of Cardiology · doi:10.1016/0002-9149(87)90998-2 · Cited by 310
Self-citationO'Gara, P. T., Bonow, R. O., Maron, B. J., Damske, B. A., Van Lingen, A., Bacharach, S. L., Larson, S. M., & Epstein, S. E. (1987) · Circulation · doi:10.1161/01.cir.76.6.1214 · Cited by 265
Self-citationDilated-Hypokinetic Evolution of Hypertrophic Cardiomyopathy
Biagini, E., Coccolo, F., Ferlito, M., Perugini, E., Rocchi, G., Bacchi-Reggiani, L., Lofiego, C., Boriani, G., Prandstraller, D., Picchio, F. M., et al. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.04.062 · Cited by 226
(1998) · The American Journal of Cardiology · doi:10.1016/s0002-9149(98)00164-7 · Cited by 166
Primary Prevention of Sudden Death as a Novel Treatment Strategy in Hypertrophic Cardiomyopathy
Maron, B. J., Estes, N. A. M., Maron, M. S., Almquist, A. K., Link, M. S., & Udelson, J. E. (2003) · Circulation · doi:10.1161/01.cir.0000072343.81530.75 · Cited by 164
Self-citationPrevalence and clinical significance of systolic impairment in hypertrophic cardiomyopathy
Thaman, R., Gimeno, J. R., Murphy, R. T., Kubo, T., Sachdev, B., Mogensen, J., Elliott, P. M., & McKenna, W. J. (2005) · Heart · doi:10.1136/hrt.2003.031161 · Cited by 160
Coronary artery disease in hypertrophic cardiomyopathy
Cokkinos, D. V., Krajcer, Z., & Leachman, R. D. (1985) · The American Journal of Cardiology · doi:10.1016/0002-9149(85)90526-0 · Cited by 151
Hecht, G. M., Klues, H. G., Roberts, W. C., & Maron, B. J. (1993) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(93)90054-5 · Cited by 72
Self-citationClinicopathologic features of hypertrophic cardiomyopathy managed by cardiac transplantation
Shirani, J., Maron, B. J., Cannon, R. O., Shahin, S., & Roberts, W. C. (1993) · The American Journal of Cardiology · doi:10.1016/0002-9149(93)91136-6 · Cited by 69
Self-citationGenotype, phenotype: upstairs, downstairs in the family of cardiomyopathies
Chien, K. R. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17612 · Cited by 57
Genotype, phenotype: upstairs, downstairs in the family of cardiomyopathies
Chien, K. R. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200317612 · Cited by 48
Kawano, S., Iida, K., Fujieda, K., Yukisada, K., Magdi, E. S., Iwasaki, Y., Tabei, F., Yamaguchi, I., & Sugishita, Y. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(94)00432-p · Cited by 33
Cited by
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
Authors/Task Force members, Elliott, P. M., Anastasakis, A., Borger, M. A., Borggrefe, M., Cecchi, F., Charron, P., Hagege, A. A., Lafont, A., Limongelli, G., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu284 · Cited by 4,332
2023 ESC guidelines for the management of cardiomyopathies
Arbelo, E., Protonotarios, A., Gimeno, J. R., Arbustini, E., Barriales-Villa, R., Basso, C., Bezzina, C. R., Biagini, E., Blom, N. A., de Boer, R. A., et al. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad194 · Cited by 2,844
Paulus, W. J., Tschöpe, C., Sanderson, J. E., Rusconi, C., Flachskampf, F. A., Rademakers, F. E., Marino, P., Smiseth, O. A., De Keulenaer, G., Leite-Moreira, A. F., et al. (2007) · European Heart Journal · doi:10.1093/eurheartj/ehm037 · Cited by 2,679
Gersh, B. J., Maron, B. J., Bonow, R. O., Dearani, J. A., Fifer, M. A., Link, M. S., Naidu, S. S., Nishimura, R. A., Ommen, S. R., Rakowski, H., et al. (2011) · Circulation · doi:10.1161/cir.0b013e318223e2bd · Cited by 2,104
Self-citationMehra, M. R., Canter, C. E., Hannan, M. M., Semigran, M. J., Uber, P. A., Baran, D. A., Danziger-Isakov, L., Kirklin, J. K., Kirk, R., Kushwaha, S. S., et al. (2016) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2015.10.023 · Cited by 1,431
Metadata
- Authors
- Harris, K. M., Spirito, P., Maron, M. S., Zenovich, A. G., Formisano, F., Lesser, J. R., Mackey-Bojack, S., Manning, W. J., Udelson, J. E., & Maron, B. J.
- Venue
- Circulation
- Published
- 2006-07-18
- Volume
- 114
- Issue
- 3
- Pages
- 216-225
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2145651104
- Cited by
- 671
- References
- 28
- FWCI
- 18.59
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.